Driehaus Capital Management LLC Purchases New Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Driehaus Capital Management LLC acquired a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 187,449 shares of the company's stock, valued at approximately $10,122,000. Driehaus Capital Management LLC owned about 2.02% of Semler Scientific at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Cetera Investment Advisers bought a new stake in shares of Semler Scientific in the fourth quarter worth about $965,000. Bosun Asset Management LLC bought a new stake in shares of Semler Scientific in the fourth quarter worth about $360,000. BNP Paribas Financial Markets bought a new stake in shares of Semler Scientific in the fourth quarter worth about $30,000. Boothbay Fund Management LLC bought a new stake in shares of Semler Scientific in the fourth quarter worth about $340,000. Finally, Miller Value Partners LLC bought a new stake in shares of Semler Scientific in the fourth quarter worth about $2,322,000. Institutional investors own 49.37% of the company's stock.

Semler Scientific Stock Up 0.8%

Shares of NASDAQ:SMLR traded up $0.25 during mid-day trading on Thursday, reaching $32.79. 452,321 shares of the stock were exchanged, compared to its average volume of 436,488. The company has a market cap of $314.72 million, a P/E ratio of 6.65 and a beta of 1.33. Semler Scientific, Inc. has a one year low of $21.77 and a one year high of $81.56. The stock's 50 day simple moving average is $34.90 and its 200-day simple moving average is $46.62.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The firm had revenue of $8.84 million for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Analysts Set New Price Targets

Separately, Lake Street Capital increased their price target on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a report on Friday, January 24th.

Semler Scientific Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.